Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-03

Clinical Trial Update: Efficacy and Safety of Shatavari Root Extract for Premenstrual Syndrome in Women [NA]

View source ↗

Summary

A clinical trial update for Shatavari root extract evaluating efficacy and safety for Premenstrual Syndrome in women, currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Shatavari Root Extract (Asparagus racemosus extract)

Snippet

Sponsor: SF Research Institute, Inc. | Conditions: Premenstrual Syndrome, Women Health | NA | Status: NOT_YET_RECRUITING